Cancer Drugs
Tetracycline in preventing skin rash in patients who are receiving drugs such as gefitinib and cetuximab for cancer This study is currently recruiting patients. Sponsors and collaborators: North Central Cancer Treatment Group. This randomized clinical trial is studying tetracycline to see how well it works compared to placebo in preventing skin rash in patients who are receiving drugs such as gefitinib or cetuximab for cancer.
Condition Treatment or Intervention
Unspecified adult Drug: tetracycline
solid tumor, Procedure: complications of therapy ssessment/
protocol specific management
Procedure: dermatologic complications management
Procedure: supportive care/therapy
Study ID Numbers: CDR0000385682; NCCTG-N03CB; NCT00091247
ClinicalTrials.gov Identifier: NCT00091247
COPYRIGHT 2005 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2005 Gale Group
|
